Skip to main content

Test Price

1,400 AED

✅ Home Collection Available

Hemophilia A Carrier Detection Test in UAE – 1,400 AED | DHA Licensed Lab

Executive Summary & Core Metrics

Accuracy: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited electromechanical clot detection with ELISA (Factor VIII antigen & activity).

Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection available daily 8 AM–11 PM (Dubai, Sharjah, Abu Dhabi).

Clinical Support: Post-test telephonic interpretation by a DHA-licensed Consultant Medical Geneticist.

Billing: Direct insurance verification via WhatsApp +971 54 548 8731. Self-pay price: 1,400 AED.

Test Overview & Methodology

This molecular carrier detection test identifies females carrying one altered copy of the Factor VIII gene (F8) on the X chromosome. It uses a combination of electromechanical clot detection (modified APTT-based) and quantitative ELISA for Factor VIII antigen and activity, providing >99.9% sensitivity for carrier status. The specimen required is 3 mL whole blood in a 3.2% sodium citrate tube (blue top). Overnight fasting is preferred but not mandatory. Sample collection is accepted Monday through Wednesday before 11 AM for next-day reporting.

Feature Our Test Closest Alternative
Precision Electromechanical clot detection + ELISA (Factor VIII antigen & activity) – ISO-validated Basic APTT-based screening (low carrier sensitivity)
Method Coagulation clot endpoint with antigenic Factor VIII assay Clotting time assay without antigen quantification
Speed Next-day report (sample received Mon–Wed by 11 AM) 3–5 working days (standard lab workflow)

Physician Insight & Safety Protocols

“Carrier testing for Hemophilia A provides clarity for reproductive planning and family counselling. A negative clotting study does not definitively exclude carrier status – correlation with family history and, if indicated, genetic sequencing is essential. I recommend this test following thorough pre-test counselling and never as a standalone emergency test.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License 9294403

⚠️ Medication Advisory

Do not discontinue any prescribed medication without physician approval.

If you are using Heparin or oral anticoagulants (e.g., warfarin, rivaroxaban), temporary cessation must be authorized by your treating doctor. Typically, Heparin is stopped 1 day and oral anticoagulants 7 days before sampling. Always carry your medication list to the collection visit.

Exclusion Criteria & Emergency Red Flags

  • Active bleeding or unexplained bruising – inform your physician; do not proceed with elective phlebotomy.
  • Known hypersensitivity to latex (tourniquet) or severe anemia – reschedule after medical clearance.
  • If the test result is unexpectedly abnormal and you develop severe headache, vision changes, or joint swelling, seek emergency care immediately.

Patient FAQ & Clinical Guidance

1. What does a positive Hemophilia A Carrier Detection result mean?

A positive result indicates that you carry one altered copy of the Factor VIII gene on the X chromosome – making you a carrier. This does not mean you have hemophilia, but your male children have a 50% chance of inheriting the condition. Clinical correlation with family history and genetic counselling is strongly advised.

2. How should I prepare for the Hemophilia A Carrier Detection test?

Overnight fasting is preferred but not mandatory. You must complete a coagulation requisition form (Form 15). With physician consent, discontinue Heparin 1 day and oral anticoagulants 7 days before blood draw. Wear clothing that allows easy access to your arm.

3. Can I do the test at home in the UAE?

Yes. Our DHA-licensed mobile phlebotomists collect the sample from your residence daily between 8 AM and 11 PM using ISO-certified cold-chain transport to ensure sample integrity. Home collection is available in all Emirates.

UAE Regulatory & Data Privacy Adherence

Data Protection: All patient data is processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Clinical Safety: Patient consent and clinical safety procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.

Accreditation: DNA Labs UAE is ISO 9001:2015 certified (Cert. INT/EGQ/2509DA/3139) and holds DHA Facility License No. 1143.

Clinical & Logistical Metadata

Test Name Hemophilia A Carrier Detection (Factor VIII Antigen & Activity)
Price (AED) 1,400 AED
Turnaround Time Next day (sample received Mon–Wed by 11 AM; report delivered following working day)
Sample Type / Matrix 3 mL whole blood in 3.2% sodium citrate (blue top) – transport within 4 hours; or platelet-poor plasma (PPP) frozen
Methodology Used Electromechanical clot detection (modified APTT) + quantitative ELISA (Factor VIII antigen & activity)
ICD-10-CM Code Z14.01
LOINC Code 3209-5
DHA Facility License & Laboratory Address DHA License No. 1143
Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
DNA Labs UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians